OBJECTIVE: This study examined prospective data from the Third National Health and Nutrition Examination Survey (NHANES III) cohort to investigate the relationship between cadmium exposure and cancer mortality, and the specific cancers associated with cadmium exposure, in the general population. METHODS: Vital status and cause of death through 31 December 2006 were obtained by the National Center for Health Statistics for NHANES III participants. The cadmium concentration of spot urine samples was measured and corrected for urine creatinine (uCd). Weighted Cox proportional hazards regression with age as the time metric was applied to estimate sex-specific adjusted HRs (aHRs) of mortality associated with uCd for all cancers and the cancers responsible for the most deaths in the USA. Estimates were stratified by smoking history and adjusted for education, body mass index and race. RESULTS: uCd was associated with cancer mortality (aHR per twofold higher uCd (95% CI), men: 1.26 (1.07 to 1.48); women: 1.21 (1.04 to 1.42)). In men, mortality from lung cancer, pancreatic cancer and non-Hodgkin lymphoma was associated with uCd; an association with leukaemia mortality was suggested. In women, associations were suggested with mortality due to lung cancer, leukaemia, ovarian and uterine cancer, but evidence was weaker than in men. CONCLUSIONS: Cadmium appears to be associated with overall cancer mortality in men and women, but the specific cancers associated differ between men and women, suggesting avenues for future research. Limitations of the study include the possibility of uncontrolled confounding by cigarette smoking or other factors, and the limited number of deaths due to some cancers.
OBJECTIVE: This study examined prospective data from the Third National Health and Nutrition Examination Survey (NHANES III) cohort to investigate the relationship between cadmium exposure and cancer mortality, and the specific cancers associated with cadmium exposure, in the general population. METHODS: Vital status and cause of death through 31 December 2006 were obtained by the National Center for Health Statistics for NHANES III participants. The cadmium concentration of spot urine samples was measured and corrected for urine creatinine (uCd). Weighted Cox proportional hazards regression with age as the time metric was applied to estimate sex-specific adjusted HRs (aHRs) of mortality associated with uCd for all cancers and the cancers responsible for the most deaths in the USA. Estimates were stratified by smoking history and adjusted for education, body mass index and race. RESULTS: uCd was associated with cancer mortality (aHR per twofold higher uCd (95% CI), men: 1.26 (1.07 to 1.48); women: 1.21 (1.04 to 1.42)). In men, mortality from lung cancer, pancreatic cancer and non-Hodgkin lymphoma was associated with uCd; an association with leukaemia mortality was suggested. In women, associations were suggested with mortality due to lung cancer, leukaemia, ovarian and uterine cancer, but evidence was weaker than in men. CONCLUSIONS:Cadmium appears to be associated with overall cancer mortality in men and women, but the specific cancers associated differ between men and women, suggesting avenues for future research. Limitations of the study include the possibility of uncontrolled confounding by cigarette smoking or other factors, and the limited number of deaths due to some cancers.
Authors: Dominik D Alexander; Pamela J Mink; Hans-Olov Adami; Ellen T Chang; Philip Cole; Jack S Mandel; Dimitrios Trichopoulos Journal: Int J Cancer Date: 2007 Impact factor: 7.396
Authors: Jane A McElroy; Martin M Shafer; Amy Trentham-Dietz; John M Hampton; Polly A Newcomb Journal: J Natl Cancer Inst Date: 2006-06-21 Impact factor: 13.506
Authors: Alina Vrieling; H Bas Bueno-de-Mesquita; Hendriek C Boshuizen; Dominique S Michaud; Marianne T Severinsen; Kim Overvad; Anja Olsen; Anne Tjønneland; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Rudolf Kaaks; Sabine Rohrmann; Heiner Boeing; Ute Nöthlings; Antonia Trichopoulou; Eftihia Moutsiou; Vardis Dilis; Domenico Palli; Vittorio Krogh; Salvatore Panico; Rosario Tumino; Paolo Vineis; Carla H van Gils; Petra H M Peeters; Eiliv Lund; Inger T Gram; Laudina Rodríguez; Antonio Agudo; Nerea Larrañaga; María-José Sánchez; Carmen Navarro; Aurelio Barricarte; Jonas Manjer; Björn Lindkvist; Malin Sund; Weimin Ye; Sheila Bingham; Kay-Tee Khaw; Andrew Roddam; Tim Key; Paolo Boffetta; Eric J Duell; Mazda Jenab; Valentina Gallo; Elio Riboli Journal: Int J Cancer Date: 2010-05-15 Impact factor: 7.396
Authors: Alexandra Nieters; Sabine Rohrmann; Nikolaus Becker; Jakob Linseisen; Thomas Ruediger; Kim Overvad; Anne Tjønneland; Anja Olsen; Naomi E Allen; Ruth C Travis; Sheila Bingham; Kay-Tee Khaw; Eva Ardanaz; M L Redondo; Mikel Basterrechea; Carmen Martinez; María-José Tormo; Stefano Rosso; Giovanna Tagliabue; Giovanna Masala; Amalia Mattiello; Rosario Tumino; Heiner Boeing; Manuela Bergmann; Rudolf Kaaks; Antonia Trichopoulou; Dimitrios Trichopoulos; Petra H Peeters; Bas Bueno-de-Mesquita; Paolo Boffetta; Paul Brennan; Pietro Ferrari; David Neasham; Eiliv Lund; Göran Berglund; Jonas Manjer; Göran Hallmans; Ingegerd Johansson; Paolo Vineis; Elio Riboli Journal: Am J Epidemiol Date: 2008-03-04 Impact factor: 4.897
Authors: Andy Menke; Paul Muntner; Ellen K Silbergeld; Elizabeth A Platz; Eliseo Guallar Journal: Environ Health Perspect Date: 2008-09-03 Impact factor: 9.031
Authors: Scott V Adams; Martin M Shafer; Matthew R Bonner; Andrea Z LaCroix; JoAnn E Manson; Jaymie R Meliker; Marian L Neuhouser; Polly A Newcomb Journal: Am J Epidemiol Date: 2016-03-31 Impact factor: 4.897
Authors: Omar Hyder; Michael Chung; David Cosgrove; Joseph M Herman; Zhiping Li; Amin Firoozmand; Ahmet Gurakar; Ayman Koteish; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2013-05-01 Impact factor: 3.452